Palisade Bio (PALI) Treasury Shares (2020 - 2022)

Palisade Bio (PALI) has reported Treasury Shares for 11 consecutive years, with $24.8 million the latest figure, recorded in Q4 2025.

• In Q4 2025, Treasury Shares changed N/A year-over-year to $24.8 million; the TTM figure through Dec 2025 stood at $24.8 million (changed N/A YoY), while the FY2025 annual figure was $24.8 million, changed N/A from the prior year.
• Treasury Shares improved to $24.8 million in Q4 2025 per PALI's latest filing, from $24195.0 in the prior quarter.
• Across five years, Treasury Shares topped out at $24.8 million in Q4 2025 and bottomed at $24195.0 in Q4 2023.
• Historically, Treasury Shares has averaged $7.6 million across 4 years, with a median of $6.0 million in 2021.
• Annual changes were most pronounced in 2021 — Treasury Shares jumped 612072.57% — and 2023, when it tumbled 97.06%.
• Palisade Bio's Treasury Shares stood at $11.7 million in 2021, then changed by 0.0% to $11.7 million in 2022, then plunged by 99.79% to $24195.0 in 2023, then surged by 102593.12% to $24.8 million in 2025.
• Business Quant data shows PALI's Treasury Shares at $24.8 million in Q4 2025, $24195.0 in Q4 2023, and $342970.0 in Q3 2023.